Supernus Pharmaceuticals Inc (SUPN)
Stock-Based Compensation
$8.64M
Quarterly · Period ending: · USD
SUPN Stock-Based Compensation
Latest reported$8.64Mperiod ending
Latest reported$8.64Mperiod ending
SUPN Quarterly Stock-Based Comp ($27.97K → $8.64M)
Quarterly stock-based compensation
High-resolution chart · PNG
SUPN stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,640,000 | |
| 8,480,000 | |
| 33,051,000 | |
| 7,825,000 | |
| 7,507,000 | |
| 8,068,000 | |
| 7,632,000 | |
| 7,674,000 | |
| 6,552,000 | |
| 5,897,000 | |
| 6,445,000 | |
| 7,920,000 | |
| 6,088,000 | |
| 6,306,000 | |
| 4,261,000 | |
| 4,985,000 | |
| 4,297,000 | |
| 4,025,000 | |
| 4,036,000 | |
| 4,027,000 | |
| 5,476,000 | |
| 4,371,000 | |
| 3,121,000 | |
| 4,490,000 | |
| 4,962,000 | |
| 3,988,000 | |
| 3,623,000 | |
| 3,914,000 | |
| 4,022,000 | |
| 3,287,000 | |
| 2,991,000 | |
| 2,597,000 | |
| 3,068,000 | |
| 2,635,000 | |
| 1,986,000 | |
| 2,360,000 | |
| 2,260,000 | |
| 1,827,000 | |
| 1,472,000 | |
| 1,483,000 | |
| 1,612,000 | |
| 1,359,000 | |
| 1,079,000 | |
| 1,132,000 | |
| 977,000 | |
| 902,000 | |
| 693,000 | |
| 806,000 | |
| 652,000 | |
| 667,000 | |
| 653,000 | |
| 491,000 | |
| 432,000 | |
| 337,000 | |
| 208,000 | |
| 130,000 | |
| 53,000 | |
| 52,000 | |
| -38,000 | |
| 48,000 | |
| 48,000 | |
| -140,000 | |
| 173,008 | |
| 27,969 |